Goldman Sachs Knock-Out AZN/ DE000GG4QVB7 /
2024-06-25 9:49:16 AM | Chg.+0.07 | Bid10:00:41 PM | Ask10:00:41 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.06EUR | +2.34% | - Bid Size: - |
- Ask Size: - |
Astrazeneca PLC ORD ... | 99.2624 GBP | 2078-12-31 | Call |
GlobeNewswire
10:30 PM
Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
GlobeNewswire
06-18
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire
06-18
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire
06-13
Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...